相关实验视频
Updated: Jun 22, 2025

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
预后枢纽基因POLE2通过PI3K/AKT信号通路促进BLCA细胞生长
Dongzhen Jiang1, Huawei Zhang1, Bingde Yin1
1Department of Urology, Minhang Hospital, Fudan University, 170 Xin-Song Road, Shanghai, 201199, China.
这项研究确定了POLE2作为膀癌 (BLCA) 中的关键瘤基因和预后生物标志物. 针对POLE2可以通过PI3K/AKT通路抑制BLCA的扩散,从而提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- 膀癌 (BLCA) 是一种普遍存在的尿路细胞恶性瘤,复发率很高.
- 推动BLCA发展的分子机制需要进一步阐明.
研究的目的:
- 为了确定BLCA的新型预后生物标志物.
- 调查BLCA进展中已识别的生物标志物的潜在分子机制和功能作用.
主要方法:
- 权重基因共同表达网络分析 (WGCNA) 针对来自GSE42089和TCGA-BLCA数据集的重叠差异表达基因 (DEG) 进行.
- 生物信息分析包括MCODE,预后风险建模和免疫组织化学染色,用于确定预后枢纽基因.
- 进行了体外细胞功能测试,以验证已识别的枢纽基因在BLCA增殖和信号通路中的作用.
主要成果:
- WGCNA确定了一个关键的蓝色模块,随后的分析确定了POLE2作为潜在候选人中的预后枢纽基因 (TROAP,POLE2,ANLN,E2F8).
- 在BLCA中观察到升高的POLE2表达,与明显的临床特征相关.
- 沉默POLE2 (si-POLE2) 抑制了BLCA细胞的增殖,并提高了PI3K/AKT信号的调节.
结论:
- 在膀癌中,POLE2作为瘤基因和有前途的预后生物标志物起作用.
- POLE2通过PI3K/AKT信号通路促进BLCA的进展,表明其作为治疗点的潜力.
更多相关视频
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer Cell Migration through Invadopodia